Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months

✍ Scribed by James C. King Jr.; Manon M. Cox; Keith Reisinger; James Hedrick; Irene Graham; Peter Patriarca

• Book ID: 116961924
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 142 KB
• Volume: 27
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2009.08.032